November 2, 2023
Webinar
Finnegan
Innovators in the pharmaceutical field must conduct clinical trials in order to market their products. These trials often provide the basis for secondary patents that protect innovative aspects of the candidate products, such as preferred formulations, combinations, dosages, new medical uses, etc. In this webinar, we consider the impact of the clinical trials on the patentability of these secondary patents.
Practical discussion will include:
Moderator:
Jamie Barcombe
Presenters:
Maeve O’Flynn
Yieyie Yang, Ph.D.
Hybrid Conference
Intellectual Property Law Institute 2026 – California
October 19-20, 2026
San Francisco
Hybrid Conference
Intellectual Property Law Institute 2026 – New York
September 28-29, 2026
New York
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.